Medical and Science Advisory Board
Scott D. Boden, MD, Chief Medical Advisor
Dr. Boden is a tenured Professor of Orthopaedic Surgery at the Emory University School of Medicine and serves as the Director of the Emory Orthopeadics & Spine Center, Vice Chair of Orthopaedics, CMO/CQO of The Emory University Orthopaedics & Spine Hospital, and Emory Healthcare Physician Director of Strategy and Development for Orthopaedics & Spine Programs.
Dr. Boden has received numerous awards for his work and is the author of more than 175 peer-reviewed articles on spine and basic science topics; as well as 30 chapters and seven textbooks. He is co-editor of Seminars in Spine Surgery, a deputy editor of SPINE, and a reviewer for the Journal of Bone and Joint Surgery, the Journal of Bone and Mineral Research, and the European Spine Journal.
W. Andrew Hodge, MD, FACS, Chairman & M.A.B.
A world renowned Orthopaedic Surgeon specializing in arthritis surgery and musculoskeletal research. He has been recognized for his accomplishments on CNN News, the Discovery Channel, and Science Magazine. He completed special fellowship training at both Harvard University and Massachusetts Institute of Technology. During ten years of performing surgery, research, and teaching in the Harvard/MIT system he designed and directed the BioMotion Foundation in 1987 as a non-profit organization to support orthopaedic research and education worldwide. In 1992 the BioMotion Foundation, now known as The Institute for Mobility and Longevity, was recruited to Palm Beach, Florida, by Good Samaritan Medical Center. This clinical and research operation combined world-class orthopaedic surgeons with the latest advances in bioengineering and computer technology.
Robert D. Sheeler, MD
Dr. Sheeler is a Boarded Family Medicine Physician who served as Clinical Practice Chair for the Department of Family Medicine and as director of the Mayo Clinic Urgent Care Center which saw up to 80,000 patients/year during his time as Chair. Additionally, he is Board Certified in Urgent Care and Integrative Medicine and is also trained and certified in Functional Medicine through the Institute for Functional Medicine. He is also a NAMS - North American Menopause Society Certified Practitioner.
He is also a Headache Specialist certified by the United Council of Neurologic Subspecialists. While at Mayo he oversaw the NeuroPsychiatric Medicine group for a decade. Dr. Sheeler received numerous awards for teaching, clinical care and leadership during his tenure at Mayo.
He has published in major journals and text-books on a wide variety of fields from headache and strep throat to medical school teaching, resource allocation and medication reconciliation.
Dr. Sheeler is now in private practice in Scottsdale, Arizona. He serves as the Chief Medical Officer for Destiny Well, a company focused on bringing leading edge solutions to health activated consumers and designing programs to be implemented through physicians' offices. He is also the Chief Medical Officer of GreenIkon USA where he is collaborating to teach and bring Functional Medicine models of care to China.
Dr. Sheeler has done consulting for a wide array of companies and institutions from the American Board of Family Medicine to Merck, Proctor & Gamble, and the American Physician Institute where he edits and teaches board review courses. His interest in bone health is longstanding and dates back to participation in the Alliance for Better Bone Health.
Dr. Sheeler says he sees broad ranging wellness and healing applications for Juvent not only in bone health but in broader areas of health optimization. Operation combined with world-class orthopaedic surgeons with the latest advances in bioengineering and computer technology.
Gunnar Andersson, MD, PHD
Professor and Chairman Emeritus, Department of Orthopedic Surgery Rush University Medical Center, Chicago, IL. In 1985, he moved to the United States and Rush University Medical Center as professor of orthopedic surgery. His clinical area of interest is spine (neck and back), while his research interests are disc degeneration, epidemiology and occupational biomechanics. He just completed a program project on disc degeneration, funded by the National Institutes of Health. Dr. Andersson is a past president of the Orthopaedic Research Society, the International Society for the Study of the Lumbar Spine and the American Academy of Disability Evaluating Physicians and is currently president-elect and treasurer of the International Society for the Advancement of Spine Surgery. He has been a council member of the National Institutes of Arthritis and Musculoskeletal and Skin Diseases at NIH, chairman of the Research Committee at the American Academy of Orthopaedic Surgeons and a member of three Institute of Medicine committees. He is a fellow of the American Institute for Medical and Biological Engineering.
Richard W. Treharne, PHD
Dr. Treharne has over 30 years of experience in the orthopaedic industry with over 15 years in senior management. From August 2006 to the present, Dr. Treharne has held the position of Vice President, Orthopaedic Research at Active Implants Corporation, a privately held orthopaedic company focused on innovative technologies for sixteen years at Medtronic Sofamor Danek, from November 1990 to August 2006, he served as a Group Director - Regulatory and Clinical Affairs for three months and then various Vice President positions for the remainder of his tenure, most recently as Vice President - Regulatory Affairs. He also held several director level positions at Smith & Nephew PLC prior to working at Medtronic. Dr. Treharne holds and M.B.A. from the University of Pennsylvania, and a B.S. in Metallurgical Engineering from The Ohio State University. Dr. Treharne's experience in senior management and the orthopaedic industry provide strategic and practical knowledge to our Board related to regulatory, clinical research and other operational areas in our industry.
David L. Brumfield, MS
Mr. Brumfield has 36 years of experience in product development for Orthopaedics, Spine, and Extremities. He holds over 40 U.S. patents, many for products which have become part of "standard of care" surgical solutions, and is well-published in these fields. Having obtained his degree in Biomedical Engineering with honors from Louisiana Tech University. He began his career at Richards Manufacturing Company, which was acquired by Smith & Nephews, Inc. While there, he made significant contributions to many novel orthopaedic trauma products, including cephalomedullary nails. In 1991, Mr. Brumfield joined Danek Medical and was ultimately named Vice President of Product Development as the company became Medtronic Sofamor Danek. During his 15-year tenure there, he helped pioneer the use of titanium in spinal implants as well as minimally invasive surgical instrumentation, and was inducted into the Bakkan Society, Medtronic's highest technical honor. Returning to Smith & Nephew in 2006, he headed R&D for its trauma division and led that team in several novel developments, including a unique electromagnetic method for distal targeting of intramedullary nails and new biomaterial technologies for the treatment of difficult fractures, including securing a DARPA grant to develop completely resorbable fracture stabilization for diaphyseal fractures with segmental bone loss. In addition, he was responsible for Product Development & Regulatory Affairs for the business segment which included the Exogen ultrasonic bone healing system and Supartz join fluid therapy products. In recent years, he has consulted for several emerging technology companies.
"I have spent my entire career trying to restore or enhance the musculoskeletal welfare of patients with the proper employment of biomedical engineering principles. I joined the Science Advisory Board of Juvent to help do just that. I consider the technology to be sound and believe its use could significantly improve the health of countless people."
Juvent's Mission
Juvent delivers clinically validated solutions to improve musculoskeletal health. Our patented Micro-Impact Platform® has clinically demonstrated the ability to help users manage and improve their bone health non-invasively. Additionally, our technology helps users decrease joint pain and increase lymphatic drainage. Juvent’s Micro-Impact is an essential ingredient for total health and vitality; a Vitamin of Exerciseˇ
Juvent Amazing History
Juvent Health was founded and led by Jack Ryaby, renowned medical device pioneer and expert in bone growth stimulation. Jack was the founder of EBI, the pioneers in magnetic bone growth stimulation and later Exogen, ultrasonic bone growth stimulation. While exploring ways to strengthen particular bone areas, he discovered Juvent’s amazing micro-impact, resonant technology—and was astonished to find that it demonstrated significant benefits throughout the entire body.
After assembling his team of experts from his earlier bone growth successes and millions in research and development funds, Juvent was born. Now the subject of numerous studies and clinical trials that confirm the amazing medical benefits, Juvent Health has won the support of clinicians and consumers, from like tennis legends Mats Wilander and Mike Bryan, golf coach David Leadbetter, and football legend Eric Woods to thousands of everyday users seeking a safer, easier, and more effective way to rejuvenate and reinforce their bodies.
Whitepapers
Clinical Benefits of Juvent's Micro-Impact Platform
This whitepaper highlights the clinical benefits of the Juvent Micro-Impact Platform®, showcasing its proven ability to enhance bone health, improve mobility, and support recovery through safe, non-invasive micro-impact therapy. Backed by extensive research, it’s your guide to understanding the transformative health impacts of Juvent.
Differentiating Human Health Benefits: Micro-Impact vs. Whole Body Vibration
This whitepaper compares Juvent's Micro-Impact Therapy with traditional whole-body vibration (WBV) platforms, highlighting its superior safety, precision, and effectiveness. Backed by clinical research, it demonstrates how Juvent delivers targeted benefits for bone health, mobility, and recovery without the risks associated with WBV.
Human Health Benefits of Low Magnitude Mechanical Stimulation (LMMS)
This whitepaper explores the science and clinical evidence behind Low-Magnitude Mechanical Signals (LMMS) and their profound impact on human health. It highlights how Juvent’s Micro-Impact Platform® harnesses LMMS to improve bone density, enhance mobility, and support overall well-being, offering a safe, non-invasive approach to long-term health benefits.
Juvent's Micro-Impact Platform for Increasing Bone Mineral Density in Pediatric Cancer Survivors
This whitepaper examines the role of Juvent's Micro-Impact Platform® in supporting cancer survivors. It highlights how Micro-Impact Therapy can help mitigate the effects of bone loss, improve mobility, and enhance overall quality of life following treatment. Backed by clinical research, the paper underscores Juvent’s safe and effective approach to addressing the unique health challenges faced by cancer survivors.